Streetbeat News

Equity Actions

BTCUSD

GOOGL

PLTR

The US markets are set to rebound on hopes of jobs data swaying the Fed. Analysts predict a bull run into September and see more than 7% upside in Alphabet. Bitcoin's brief spikes on alleged good news quickly reversed. The Biden administration commits $15.5B to upgrade automaker factories for EV production. Morgan Stanley boosts Palantir stake by 50% in Q2, then slaps it with a 'Sell' tag.

Portfolio Pulse from Akanksha Bakshi

September 01, 2023 | 12:22 pm

HOOD

Robinhood has purchased 55,273,469 shares of its Class A common stock from the U.S. Marshal Service for a total of $605,694,411.59. The transaction was approved by the U.S. District Court for the Southern District of New York.

Portfolio Pulse from Happy Mohamed

September 01, 2023 | 12:17 pm

NVOS

Novo Integrated Sciences has received an Underwriting Clearance Notice for a $70 million coupon, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 12:14 pm

NTNX

Nutanix reported better-than-expected Q4 financial results and announced a share repurchase program, leading to a rise in its share price.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 12:13 pm

SCWO

374Water's CEO Yaacov 'Kobe' Nagar has announced his immediate resignation as part of a strategic realignment. The company has not yet announced a successor.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 12:07 pm

ILLM

illumin Holdings Inc. (NASDAQ:ILLM) has announced its intention to voluntarily delist its common shares from the NASDAQ Stock Market. The company believes the costs and administrative requirements of maintaining a dual listing are not justified. The shares will continue to trade on the Toronto Stock Exchange (TSX). The delisting from NASDAQ is expected to occur on or about September 11, 2023.

Portfolio Pulse from Happy Mohamed

September 01, 2023 | 12:03 pm

LUXH

LuxUrban Hotels Inc. (NASDAQ:LUXH) has reiterated its commitment to growth through non-dilutive funding options, supported by its recent agreement with Wyndham Hotels & Resorts and successful balance sheet initiatives. The agreement with Wyndham will provide LuxUrban with approximately 50% or more of all capital required for new acquisitions. The company expects to open at least 60% of its current hotels under the Trademark Collection banner by September 30, 2023. Additionally, Greenle Partners LLC, the company's second largest shareholder, has agreed to waive all registration rights on all prior share issuances for a minimum of 12 months.

Portfolio Pulse from Happy Mohamed

September 01, 2023 | 12:02 pm

WIMI

WiMi Hologram Cloud Inc. (NASDAQ:WIMI) has developed a multi-objective 3D modeling and reconstruction system based on artificial intelligence techniques. The system is characterized by high scalability, ease of use, and multifunctionality. It includes point cloud data acquisition, data preprocessing, feature point extraction, and mesh reconstruction. The system also supports functions such as 3D visualization, object recognition, and 3D reconstruction. The development of this system promotes the innovation of AI technology in the field of 3D image processing.

Portfolio Pulse from Happy Mohamed

September 01, 2023 | 12:00 pm

EOSE

Eos Energy Enterprises Inc's shares are surging after the company launched Project AMAZE, a $500 million expansion to build 8 GWh of clean energy storage production capacity. The Department of Energy's Loan Programs Office has issued a conditional commitment for a loan guarantee of up to $398.6 million, expected to fund 80% of the expansion. The project aims to meet increased long-duration energy storage demand and expand the U.S. supply chain.

Portfolio Pulse from Shivani Kumaresan

September 01, 2023 | 11:58 am

VRAX

Virax Biolabs Group Limited (NASDAQ:VRAX) has appointed Dr. Nigel McCracken as its new Chief Operating Officer (COO). Dr. McCracken, who has over 10 years of experience in diagnostics and has held operational roles at multinational healthcare companies including Abbott Laboratories, will succeed Mr. Cameron Shaw. Shaw is moving to Virax's Advisory Board. Dr. McCracken will lead the company's growth initiatives, including the expected near-term research-use-only launch of ViraxImmune™. Mark Ternouth, Virax's current Chief Technology Officer, will be joining the company's Board of Directors.

Portfolio Pulse from Happy Mohamed

September 01, 2023 | 11:48 am